Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysine rich nucleolar protein 1 pseudogene 4 (KNOP1P4) is a human pseudogene corresponding to the lysine rich nucleolar protein 1 gene. Pseudogenes like KNOP1P4 are fragments or copies of genes that have lost their protein-coding ability through mutations. While many pseudogenes may be transcriptionally inactive, some are transcribed into non-coding RNA and may have regulatory roles, such as acting as microRNA decoys or influencing the stability of related transcripts. However, as of current knowledge, there is no direct evidence that KNOP1P4 has a specific biological or pathological function, nor is it considered a therapeutic target. There are no documented roles associating KNOP1P4 specifically with disease processes or as a biomarker. It is not a classical therapeutic target and does not encode a functional protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysine rich nucleolar protein 1 pseudogene 4 (KNOP1P4).